Application 217221
- Type
- ANDA
- Sponsor
- DIFGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LIDOCAINE | LIDOCAINE | PATCH;TOPICAL | 1.8% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217221-001 | LIDOCAINE | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217221-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217221-001 | LIDOCAINE | 1.8% | PATCH / TOPICAL | AB | 2025-03-25 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217221-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A217221-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A217221-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217221-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A217221-001 | AB | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217221-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| lidocaine | LIDOCAINE | Proficient Rx LP | f9b290d2-0e24-4ca8-bca2-3016f5c404df | 2022-05-01 | Warnings, Adverse reactions | lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Actavis Pharma, Inc. | 4d04052c-3e0a-469a-9265-99604f13e507 | 2022-04-30 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Proficient Rx LP | 2c396307-cf12-41d0-89e6-0f4ec74df55e | 2022-04-01 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | AVKARE | ec6a4720-9821-c0fc-e053-2995a90a05df | 2022-04-01 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| lidocaine | LIDOCAINE | Glenmark Pharmaceuticals Inc., USA | eaa15be7-11ea-49bc-ac07-739075453be6 | 2021-08-20 | Warnings, Adverse reactions | lidocaine LIDOCAINE |
| lidocaine | LIDOCAINE | Asclemed USA, Inc. | 6abf3773-0e60-48b1-9d5c-adc590363d13 | 2021-08-09 | Warnings, Adverse reactions | lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Proficient Rx LP | f1007717-528a-42e2-94aa-db0edf3bb603 | 2021-01-01 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidoxryl | LIDOCAINE | PureTek Corporation | 1c33790b-8d57-46e8-bd6e-5a0f87a3c29f | 2020-11-10 | Warnings, Adverse reactions | LIDOCAINE |
| LidoPure Patch | LIDOCAINE | PureTek Corporation | c851c6e9-1966-4639-9406-fe6adc91c9d0 | 2020-11-10 | Warnings, Adverse reactions | LIDOCAINE |
| Lidocaine | LIDOCAINE | Asclemed USA, Inc. | c18f0c2b-cd05-4458-888f-47b4a1106937 | 2020-11-03 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Proficient Rx LP | cbf01b82-c43f-4bed-a1df-7569f4816c76 | 2019-11-01 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Lidocaine | LIDOCAINE | Amneal Pharmaceuticals LLC | d1509740-f9f1-44e3-8fde-51d8683fcd87 | 2018-10-28 | Warnings, Adverse reactions | Lidocaine LIDOCAINE |
| Deeveeant Numb | LIDOCAINE | Valekista Limited | 2d7b39cc-4f1b-4414-b129-88c56e159aba | 2017-07-06 | Warnings | LIDOCAINE |
| MediNumb | LIDOCAINE | Valekista Limited | 0e43648d-3dae-4faf-a6b4-d21c062e32e1 | 2017-07-06 | Warnings | LIDOCAINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.